Seeking Alpha

Abbott Unveils Late-Breaking Data Showing the World's First Dual-Chamber Leadless Pacemaker Study Met All Three Primary Endpoints

NEW ORLEANS, May 20, 2023 /PRNewswire/ -- Abbott today announced late-breaking results from the AVEIR™ dual-chamber (DR) i2i™ Investigational Device Exemption (IDE) study, a large-scale study to ...
FierceBiotech

Abbott reels in FDA approval for dual-chamber leadless pacemaker

Just a few weeks after Abbott presented the successful results of a trial of its Aveir DR dual-chamber leadless pacemaker system—data that it said had been promptly submitted for regulatory review—the ...
Forbes

FDA Gives The Okay For Abbott’s New Minimally Invasive Pacemaker

On Wednesday, medtech giant Abbott announced that its new leadless pacemaker system, Aveir DR, has been approved by the FDA. This is the first time the FDA has given a thumbs up to a device of this ...
Forbes

Restoring Cardiac Function With Dual-Chamber Leadless Pacemakers

This story is part of a series on the current progression in Regenerative Medicine. This piece discusses the regeneration of the cardiovascular system. In 1999, I defined regenerative medicine as the ...
Seeking Alpha

FDA approves Abbott dual-chamber leadless pacemaker Aveir DR

Abbott (NYSE:ABT) said it has received FDA approval for its dual-chamber leadless pacemaker system Aveir DR for the treatment of slow or abnormal heart rhythms. The medical device maker said the ...
BioWorld

Abbott snares FDA approval for leadless, dual-chamber Aveir pacemaker

Leadless cardiac electrophysiology devices have been around for a while now, but Abbott Laboratories of Abbott Park, Ill., has managed to beat the competition in the market for dual chamber pacing via ...